|
31
|
Modified and Dysfunctional Lipoproteins in Atherosclerosis: Effectors or Biomarkers?
Orekhov AN, Sobenin IA.
Curr Med Chem. 2018 Mar 20. doi: 10.2174/0929867325666180320121137. [Epub ahead of print]
|
|
32
|
Phytotherapy for the Prevention of Atherosclerosis-Associated Early Cerebral Ischemia.
Kirichenko TV, Myasoedova VA, Sobenin IA, Orekhov AN.
Curr Drug Metab. 2018;19(5):408-413. doi: 10.2174/1389200219666180305151601.
|
|
33
|
Mitochondrial genome variability: the effect on cellular functional activity.
Volobueva AS, Melnichenko AA, Grechko AV, Orekhov AN.
Ther Clin Risk Manag. 2018 Feb 9;14:237-245. doi: 10.2147/TCRM.S153895. eCollection 2018.
|
|
34
|
Potential of anti-inflammatory agents for treatment of atherosclerosis.
Chistiakov DA, Melnichenko AA, Grechko AV, Myasoedova VA, Orekhov AN.
Exp Mol Pathol. 2018 Jan 31;104(2):114-124. doi: 10.1016/j.yexmp.2018.01.008. [Epub ahead of print]
|
|
35
|
The role of monocytosis and neutrophilia in atherosclerosis.
Chistiakov DA, Grechko AV, Myasoedova VA, Melnichenko AA, Orekhov AN.
J Cell Mol Med. 2018 Jan 24. doi: 10.1111/jcmm.13462. [Epub ahead of print]
|
|
36
|
New biomarkers for diagnosis and prognosis of localized prostate cancer.
Chistiakov DA, Myasoedova VA, Grechko AV, Melnichenko AA, Orekhov AN.
Semin Cancer Biol. 2018 Jan 19. pii: S1044-579X(17)30288-2. doi: 10.1016/j.semcancer.2018.01.012. [Epub ahead of print]
|
|
37
|
Mutations of nuclear and mitochondrial genomes as potential targets for the treatment of metabolic syndrome.
Galitsyn EV, Zhelankin AV, Sobenin IA, Orekhov AN.
Curr Pharm Des. 2018 Jan 15. doi: 10.2174/1381612824666180115120725. [Epub ahead of print]
|
|
38
|
Modified lipoproteins as biomarkers of atherosclerosis.
Orekhov AN, Sobenin IA.
Front Biosci (Landmark Ed). 2018 Mar 1;23:1422-1444.
|
|
39
|
Influence of autophagy on the genesis and development of atherosclerosis and its risk factors.
Sazonova MA, Sinev VV, Karagodin VP, Ryzhkova AI, Galitsyna EV, Barinova VA, Zelinyĭ RI, Nikitina NA, Orekhov AN.
Angiol Sosud Khir. 2017;23(4):20-28.
|
|
40
|
Calcifying Matrix Vesicles and Atherosclerosis.
Chistiakov DA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN.
Biomed Res Int. 2017;2017:7463590. doi: 10.1155/2017/7463590. Epub 2017 Nov 7.
|
